The MHRA’s AI Airlock programme is advancing patient care by trialing innovative AI technologies, significantly enhancing diagnostic processes—cutting bowel cancer test times and aiding early detection of skin and eye diseases. This second phase involves seven manufacturers testing AI tools in a controlled environment, focusing on safety, efficacy, and regulatory challenges associated with AI as medical devices. Insights from real-world applications will shape future MHRA regulatory frameworks for AI and guide the National Commission’s recommendations on health sector AI governance. Innovations include AI-assisted clinical note-taking and advanced diagnostics, empowering clinicians to make informed decisions. Health Innovation Minister Zubir Ahmed emphasized the NHS’s drive to integrate rigorously tested AI tools, aiming to position the NHS at the forefront of AI-enabled healthcare globally. The programme supports economic growth by enhancing workforce health and innovation in the UK’s life sciences sector, showcasing a collaborative effort to safely integrate AI into healthcare.
Source link
Share
Read more